Clinical Research Directory
Browse clinical research sites, groups, and studies.
ED90 of Bupivacaine After Lidocaine Test Dose with DPE and EPL
Sponsor: Brigham and Women's Hospital
Summary
The primary objective of our study is to use a biased coin up-down allocation methodology to estimate the dose of bupivacaine required after the lidocaine test dose to achieve initial effective comfort in 90% of patients (post test-dose ED90) via the epidural (DPE or EPL) technique in women undergoing labor induction or augmentation; the investigators hypothesize that the investigators will be able to determine the post test-dose ED90 of bupivacaine for each technique with adequate precision to inform the optimal doses to study in a subsequent randomized trial comparing the analgesic effects of DPE vs. EPL. The investigators also hypothesize that the post test-dose ED90 of bupivacaine is lower with a DPE technique than with a conventional epidural technique.
Official title: A Trial to Determine the Optimal Bupivacaine Dose for Initiation of Labor Epidural Pain Relief with a Lidocaine Test Dose
Key Details
Gender
FEMALE
Age Range
Any - Any
Study Type
INTERVENTIONAL
Enrollment
120
Start Date
2023-12-01
Completion Date
2026-01-31
Last Updated
2025-02-10
Healthy Volunteers
Yes
Conditions
Interventions
Bupivacaine Hydrochloride
Each subject will receive allocated dose of bupivacaine
Locations (1)
Brigham and Women's Hospital
Boston, Massachusetts, United States